Skip to content
I am BIO Podcast: How Dr. David Fajgenbaum saved his own life
In the season opener of the I am BIO Podcast, Dr. David Fajgenbaum ...
Read More
BIO at the World AMR Congress: ‘We know we’re racing against time’
Antimicrobial resistance (AMR) is one of the clear and present threats of our ...
Read More
What to know about Valley fever vaccine development
As authorities reveal 19 people at a California music festival contracted Valley fever, ...
Read More
First mpox vaccines arrive in DRC, epicenter of the international emergency
The first shipment of Jynneos mpox vaccines arrived in the Democratic Republic of ...
Read More
BIO Start-Up Stadium 2024: Meet Emerging Company winner Neuroene Therapeutics
Neuroene Therapeutics is developing mitochondrial-protective small molecules for epilepsy, Parkinson’s, and mitochondrial diseases. ...
Read More
BIO Start-Up Stadium 2024: Meet Seed-Stage winner Afreen Allam and SiNON Nano Sciences
Afreen Allam’s company, SiNON Nano Sciences, has been working tirelessly to overcome one ...
Read More
EDITORS' CHOICE
BIO files amicus brief challenging IRA drug price controls
Drug price controls in the Inflation Reduction Act (IRA) involve unconstitutional coercion and will destroy innovation in transformational treatments that save patients’ lives, the Biotechnology ...
Read More
LATEST NEWS
Health
I am BIO Podcast: How Dr. David Fajgenbaum saved his own life
In the season opener of the I am BIO Podcast, Dr. David Fajgenbaum shares his journey from patient to scientist, explaining how his battle with ...
Health
BIO at the World AMR Congress: ‘We know we’re racing against time’
Antimicrobial resistance (AMR) is one of the clear and present threats of our time, and if left unchecked could have dire consequences. In 2019, antibiotic-resistant ...
Agriculture
What to know about Valley fever vaccine development
As authorities reveal 19 people at a California music festival contracted Valley fever, a company making a Valley fever vaccine for dogs is set to ...
Health
First mpox vaccines arrive in DRC, epicenter of the international emergency
The first shipment of Jynneos mpox vaccines arrived in the Democratic Republic of Congo (DRC) on Sept. 5, according to vaccine maker Bavarian Nordic. The ...
BIO Events
BIO Start-Up Stadium 2024: Meet Emerging Company winner Neuroene Therapeutics
Neuroene Therapeutics is developing mitochondrial-protective small molecules for epilepsy, Parkinson’s, and mitochondrial diseases. The company’s CEO Sherine Chan, Ph.D., co-founded Neuroene with medicinal chemist C. ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
AGRICULTURE
Climate Change
What to know about Valley fever vaccine development
As authorities reveal 19 people at a California music festival contracted Valley fever, a company making a Valley fever vaccine ...
Read More
Federal Policy
State Policy
Innovative payment arrangements bring transformative therapies from the lab to patients
In recent years, the number of disruptive, cutting-edge therapies approved or under review by the Food and Drug Administration (FDA) ...
Read More
International
Bio's View
The economics of the Inflation Reduction Act’s impact on innovation
The announcement of “maximum fair prices” for the first 10 medicines targeted under the Inflation Reduction Act (IRA) has renewed ...
Read More
